Insulin (IV)

Form: Intravenous (IV) solution

Strength: 100 units/mL (U-100) in 10 mL vials

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

Category: Critical Care

IV Insulin, primarily Regular (short-acting) insulin, is vital in managing diabetic ketoacidosis, hyperkalemia, and perioperative glycemic control. Administered intravenously in hospital settings, it is available as a 100 units/mL solution in 10 mL vials. Key brands include Humulin® R, Novolin® R in the US, and Actrapid®, Insuman® Rapid in the EU. This formulation allows rapid onset and precise control of blood glucose. Pharma B2B platforms facilitate bulk procurement of IV Insulin from GMP-certified manufacturers, ensuring hospital-grade quality, consistent supply, and global regulatory compliance for ICUs, emergency departments, and critical care environments.